Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Integrilin MAA withdrawn; companies await PURSUIT results

April 14, 1997

Genentech granted U.S. patents for factor VIII

April 11, 1997

Cohesion initiates clinical trials of CollaSeal

April 10, 1997

Xenova reports encouraging data on antithrombotic compound

April 10, 1997

T-686 inhibits PAI-1 and development of atherosclerotic lesions

April 8, 1997

Inogatran exerts selective inhibition of thrombin in vitro

April 8, 1997

Mitsubishi Chemical describes thrombin inhibitors

April 8, 1997

Haemacure to begin pivotal trials of Hemaseel HMN

April 7, 1997

Antithrombotic effect of Yamanouchi's YM-337

April 3, 1997

E-456, a minimum functional fragment of thrombomodulin from Asahi Chemical

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026